GSK 2334470 100mg 100mg | Purity Not Available
Adooq Bioscience
GSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageGSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (IC50 ~ 10 nM).
More Information Supplier PageLactacystin is a cell-permeable, potent and selective proteasome inhibitor.
More Information Supplier PageZofenopril calcium is an angiotensin-converting enzyme ACE inhibitor.
More Information Supplier Pageacolbifene is a substance being studied in the prevention of breast cancer in women at high risk of breast cancer. Acolbifene hydrochloride binds to estrogen receptors in the body and blocks the effects of estrogen in the breast. It is a type of selective estrogen receptor modulator (SERM).
More Information Supplier Pageacolbifene is a substance being studied in the prevention of breast cancer in women at high risk of breast cancer. Acolbifene hydrochloride binds to estrogen receptors in the body and blocks the effects of estrogen in the breast. It is a type of selective estrogen receptor modulator (SERM).
More Information Supplier PageTalmapimod (SCIO-469) is a selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38?? in vitro).
More Information Supplier PageTalmapimod (SCIO-469) is a selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38?? in vitro).
More Information Supplier PageTalmapimod (SCIO-469) is a selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38?? in vitro).
More Information Supplier Page